• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

5-氟尿嘧啶掺入前核糖体RNA相关的致死性。

Lethality associated with incorporation of 5-fluorouracil into preribosomal RNA.

作者信息

Herrick D, Kufe D W

出版信息

Mol Pharmacol. 1984 Jul;26(1):135-40.

PMID:6565175
Abstract

We have previously demonstrated a highly significant relationship between incorporation of 5-fluorouracil (FUra) into total cellular RNA and loss of clonogenic survival. The present study extends these findings by demonstrating a similar relationship between incorporation of FUra into preribosomal nuclear RNA (45 S and 32 S) and lethal cellular events. The results also demonstrate that the extent of FUra incorporation into preribosomal RNA (prRNA) correlates significantly with inhibition of maturation to cytoplasmic 28 S and 18 S rRNA. These findings suggest that the incorporation of FUra into prRNA alters recognition sites involved in the processing of 45 S and 32 S RNA. These data are further supported by our finding of an enhanced degradation of (FUra)prRNA by RNase III, an enzyme implicated in the maturation of Escherichia coli prRNA and T7 mRNA. These observations suggest that the incorporation of FUra into prRNA is responsible for altered processing to cytoplasmic rRNA and cell lethality.

摘要

我们之前已经证明,5-氟尿嘧啶(FUra)掺入总细胞RNA与克隆存活能力丧失之间存在高度显著的关系。本研究通过证明FUra掺入核糖体前体核RNA(45S和32S)与致死性细胞事件之间的类似关系,扩展了这些发现。结果还表明,FUra掺入核糖体前体RNA(prRNA)的程度与成熟为细胞质28S和18S rRNA的抑制作用显著相关。这些发现表明,FUra掺入prRNA会改变参与45S和32S RNA加工的识别位点。我们发现RNase III对(FUra)prRNA的降解增强,进一步支持了这些数据,RNase III是一种与大肠杆菌prRNA和T7 mRNA成熟有关的酶。这些观察结果表明,FUra掺入prRNA是导致细胞质rRNA加工改变和细胞致死的原因。

相似文献

1
Lethality associated with incorporation of 5-fluorouracil into preribosomal RNA.5-氟尿嘧啶掺入前核糖体RNA相关的致死性。
Mol Pharmacol. 1984 Jul;26(1):135-40.
2
Specific inhibition of pre-ribosomal RNA processing in extracts from the lymphosarcoma cells treated with 5-fluorouracil.5-氟尿嘧啶处理的淋巴肉瘤细胞提取物中核糖体前体RNA加工的特异性抑制
Cancer Res. 1994 Feb 1;54(3):632-6.
3
Tamoxifen and 5-fluorouracil in breast cancer: modulation of cellular RNA.他莫昔芬与5-氟尿嘧啶治疗乳腺癌:对细胞RNA的调节作用
Cancer Res. 1983 Nov;43(11):5304-8.
4
Association of cell lethality with incorporation of 5-fluorouracil and 5-fluorouridine into nuclear RNA in human colon carcinoma cells in culture.培养的人结肠癌细胞中细胞致死率与5-氟尿嘧啶和5-氟尿苷掺入核RNA的相关性。
Mol Pharmacol. 1982 Mar;21(2):468-73.
5
5-Fluorouracil incorporation into DNA of CF-1 mouse bone marrow cells as a possible mechanism of toxicity.
Cancer Res. 1984 Apr;44(4):1358-63.
6
Precursor-dependent differences in the incorporation of fluorouracil in RNA.
Mol Pharmacol. 1986 Jun;29(6):637-42.
7
Enhanced cytotoxicity with interleukin-1 alpha and 5-fluorouracil in HCT116 colon cancer cells.白细胞介素-1α与5-氟尿嘧啶联合增强对HCT116结肠癌细胞的细胞毒性。
Oncol Res. 1994;6(12):581-91.
8
5-Fluorouracil incorporation in DNA of human breast carcinoma cells.5-氟尿嘧啶掺入人乳腺癌细胞的DNA中。
Cancer Res. 1982 Aug;42(8):3005-9.
9
Modulation of 5-fluorouracil metabolism and cytotoxicity by antimetabolite pretreatment in human colorectal adenocarcinoma HCT-8.
Cancer Res. 1981 Mar;41(3):994-9.
10
Mechanisms of sensitivity and resistance of murine tumors to 5-fluorouracil.
Cancer Res. 1980 May;40(5):1431-7.

引用本文的文献

1
5-Fluorouracil Treatment Alters the Efficiency of Translational Recoding.5-氟尿嘧啶治疗改变翻译重编码效率。
Genes (Basel). 2017 Oct 31;8(11):295. doi: 10.3390/genes8110295.
2
dUTPase inhibition augments replication defects of 5-Fluorouracil.脱氧尿苷三磷酸酶抑制增强了5-氟尿嘧啶的复制缺陷。
Oncotarget. 2017 Apr 4;8(14):23713-23726. doi: 10.18632/oncotarget.15785.
3
Standing the test of time: targeting thymidylate biosynthesis in cancer therapy.经得起时间考验的策略:以胸苷酸合成为靶点的癌症治疗。
Nat Rev Clin Oncol. 2014 May;11(5):282-98. doi: 10.1038/nrclinonc.2014.51. Epub 2014 Apr 15.
4
Personalizing colon cancer therapeutics: targeting old and new mechanisms of action.个体化结肠癌治疗:靶向新旧作用机制。
Pharmaceuticals (Basel). 2013 Aug 21;6(8):988-1038. doi: 10.3390/ph6080988.
5
New insights into the RNA-based mechanism of action of the anticancer drug 5'-fluorouracil in eukaryotic cells.新型见解:抗癌药物 5'-氟尿嘧啶在真核细胞中基于 RNA 的作用机制。
PLoS One. 2013 Nov 1;8(11):e78172. doi: 10.1371/journal.pone.0078172. eCollection 2013.
6
RNA modifications: a mechanism that modulates gene expression.RNA修饰:一种调节基因表达的机制。
Methods Mol Biol. 2010;629:1-19. doi: 10.1007/978-1-60761-657-3_1.
7
Incorporation of 5-fluorouracil into U2 snRNA blocks pseudouridylation and pre-mRNA splicing in vivo.将5-氟尿嘧啶掺入U2小核RNA可在体内阻断假尿嘧啶化和前体mRNA剪接。
Nucleic Acids Res. 2007;35(2):550-8. doi: 10.1093/nar/gkl1084. Epub 2006 Dec 14.
8
Molecular characterisation of two cell lines selected for resistance to the folate-based thymidylate synthase inhibitor, ZD1694.对两种选择出来的对基于叶酸的胸苷酸合成酶抑制剂ZD1694具有抗性的细胞系进行分子特征分析。
Br J Cancer. 1995 May;71(5):925-30. doi: 10.1038/bjc.1995.179.
9
RNA polymerase II transcripts as targets for 5-fluorouridine cytotoxicity: antagonism of 5-fluorouridine actions by alpha-amanitin.RNA聚合酶II转录本作为5-氟尿苷细胞毒性的靶点:α-鹅膏蕈碱对5-氟尿苷作用的拮抗作用。
Cancer Chemother Pharmacol. 1989;24(2):80-6. doi: 10.1007/BF00263125.
10
Clinical pharmacology of 5-fluorouracil.5-氟尿嘧啶的临床药理学
Clin Pharmacokinet. 1989 Apr;16(4):215-37. doi: 10.2165/00003088-198916040-00002.